Results 211 to 220 of about 236,151 (302)

Micro/Nanostructured Materials and Microfluidic Diagnostic Platforms Enable Multimodal Detection of Circulating Tumor Cells

Exploration, EarlyView.
Engineered micro/nanomaterials enable high‐efficiency CTC capture, release, and multimodal molecular profiling. Integrated with AI‐driven analytics, these platforms decode tumor heterogeneity and metastatic dynamics, advancing real‐time monitoring and precision oncology through DNA, RNA, and protein cross‐scale data fusion.
Hao Li, Jiaojiao Sun, Kunguo Liu, Shijie Wang, Bowen Fu, Hong Zhu, Peng Cao, Xin Han   +7 more
wiley   +1 more source

Estimating the Fraction of Hepatocellular Carcinoma and Decompensated Cirrhosis Attributable to Viral Hepatitis in England Using Electronic Health Records and Case-Notes Review. [PDF]

J Viral Hepat
Etoori D, Powell A, Trembling P, Plunkett J, Brown A, Lemoine M, Ryder S, Montague S, Pilsworth E, Bains A, Harrison L, Pavlides M, Elsharkawy A, Sabin C, Desai M, Simmons R.   +15 more
europepmc   +1 more source

Engineered molecular diagnostic strategies for hepatocellular carcinoma: Integrating flexible photonic barcodes, liquid biopsies, and AI‐enhanced sensing platforms

FlexMat, EarlyView.
Abstract Early diagnosis of hepatocellular carcinoma (HCC) remains challenging because conventional serum biomarkers, especially alpha‐fetoprotein (AFP), show limited sensitivity for early‐stage disease. Recent progress in engineered molecular diagnostics provides new opportunities to improve HCC detection through integrated material, molecular, and ...
Jingzhi Xue, Wanqi Yang, Xiaoyu Liu, Xuehui Chu, Wei Li, Jinglin Wang   +5 more
wiley   +1 more source

A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma
Zeyu Zhang,1 Hongxi Zhao,1 Pengyu Wang,2 Xueyan Geng,1 Maopeng Yin,1 Yingjie Liu,1 Shoucai Zhang,1 Yongyuan Liang,1 Jian Ji,1 Guixi Zheng1,3 1Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People’s ...
Zhang Z, Zhao H, Wang P, Geng X, Yin M, Liu Y, Zhang S, Liang Y, Ji J, Zheng G   +9 more
doaj  

IL-32 drives PR3-dependent NET formation to promote portal vein tumor thrombosis and radioresistance in HCC. [PDF]

Transl Oncol
Yao L, Pan Y, Shi G, Kang P, Luan S, Leng K.   +5 more
europepmc   +1 more source

Evaluation of the effect of Atezolizumab Fab-directed liposomal Doxorubicin on in vitro models of metastatic hepatocarcinoma

reservedIl carcinoma epatocellulare (HCC) è il tumore primario del fegato più diffuso, e rappresenta una delle principali cause di morte correlata al cancro in tutto il mondo. Tra i principali fattori di rischio associati all’insorgenza di HCC troviamo
TOFFANIN, MARGHERITA
core  

Understanding the Potential of Antibody-Drug Conjugates Functionalized Engineered Exosomes in Hepatocellular Carcinoma Therapy: A Comprehensive Narrative Review. [PDF]

Health Sci Rep
Sarkar S, Bose A, Rajak J, Mitra AK, Kumer A, Dhara B.   +5 more
europepmc   +1 more source

Hepatobiliary phase imaging in HCC: revisiting diagnostic algorithms and clinical utility of gadoxetic acid-enhanced MRI across international guidelines. [PDF]

Insights Imaging
Zhou S, Yang J, Zhang S, Song Y, Li S, Yu X, Wang S, Ju S, You T, Wang YC.   +9 more
europepmc   +1 more source

A Computed Tomography Radiomics Approach for Assessing the T Cell‐Inflamed Gene Expression Profile in Hepatocellular Carcinoma and Its Association With Immunotherapy Response [PDF]

Health Care Sci
The T cell‐inflamed gene expression profile (GEP) provides a biomarker for immunotherapy response across various cancers. We established a CT‐based radiomics model to predict the T cell‐inflamed GEP and immunotherapy response in hepatocellular carcinoma (HCC).
Tang M, Sun K, Wu D, Zou Y, Zhou J, Li B, Hu H, Peng Z, Wang J, Huang B, Feng S, Chen S.   +11 more
europepmc   +2 more sources

Molecular Signaling Pathways, Regulatory and Coactivator Networks, and Emerging Mechanisms in Hepatocellular Carcinoma. [PDF]

Biomedicines
Srivastava RK, Singh P, Lonard DM.
europepmc   +1 more source